Orthofix Medical Inc (NASDAQ:OFIX) — Market Cap & Net Worth
Market Cap & Net Worth: Orthofix Medical Inc (OFIX)
Orthofix Medical Inc (NASDAQ:OFIX) has a market capitalization of $349.24 Million ($349.24 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14202 globally and #3391 in its home market, demonstrating a -3.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orthofix Medical Inc's stock price $8.64 by its total outstanding shares 40421652 (40.42 Million). Also see total assets of Orthofix Medical Inc for a full breakdown of the balance sheet.
Orthofix Medical Inc Market Cap History: 2015 to 2026
Orthofix Medical Inc's market capitalization history from 2015 to 2026. Data shows change from $1.58 Billion to $349.24 Million (-11.73% CAGR). Also see Orthofix Medical Inc (OFIX) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Orthofix Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.01% | #385 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #1384 of 3165 |
Weight: Orthofix Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Orthofix Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Orthofix Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Orthofix Medical Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.75x
Orthofix Medical Inc's market cap is 0.75 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.46 Billion | $409.79 Million | $3.06 Million | 3.57x | 478.55x |
| 2017 | $2.21 Billion | $433.82 Million | $6.22 Million | 5.10x | 355.31x |
| 2018 | $2.12 Billion | $453.04 Million | $13.81 Million | 4.68x | 153.63x |
| 2019 | $1.87 Billion | $459.95 Million | -$28.46 Million | 4.06x | N/A |
| 2020 | $1.74 Billion | $406.56 Million | $2.52 Million | 4.27x | 690.24x |
| 2021 | $1.26 Billion | $464.48 Million | -$38.38 Million | 2.71x | N/A |
| 2022 | $829.86 Million | $460.71 Million | -$19.75 Million | 1.80x | N/A |
| 2023 | $544.88 Million | $746.64 Million | -$151.40 Million | 0.73x | N/A |
| 2024 | $705.76 Million | $799.49 Million | -$126.00 Million | 0.88x | N/A |
| 2025 | $612.79 Million | $822.31 Million | -$92.19 Million | 0.75x | N/A |
Competitor Companies of OFIX by Market Capitalization
Companies near Orthofix Medical Inc in the global market cap rankings as of September 18, 2026. Review OFIX intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Orthofix Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $177.76 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #235 globally with a market cap of $107.45 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $177.76 Billion | $102.23 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.77 |
| #235 | Stryker Corporation | NYSE:SYK | $107.45 Billion | $280.13 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Orthofix Medical Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Orthofix Medical Inc's market cap moved from $1.58 Billion to $ 349.24 Million, with a yearly change of -11.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $349.24 Million | -43.01% |
| 2025 | $612.79 Million | -13.17% |
| 2024 | $705.76 Million | +29.53% |
| 2023 | $544.88 Million | -34.34% |
| 2022 | $829.86 Million | -33.97% |
| 2021 | $1.26 Billion | -27.66% |
| 2020 | $1.74 Billion | -6.93% |
| 2019 | $1.87 Billion | -12.02% |
| 2018 | $2.12 Billion | -4.04% |
| 2017 | $2.21 Billion | +51.19% |
| 2016 | $1.46 Billion | -7.73% |
| 2015 | $1.58 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Orthofix Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $349.24 Million USD |
| MoneyControl | $349.24 Million USD |
| MarketWatch | $349.24 Million USD |
| marketcap.company | $349.24 Million USD |
| Reuters | $349.24 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Orthofix Medical Inc
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhanc… Read more